A specialized nerve and muscle test that is highly sensitive for detecting myasthenia gravis, particularly when other tests are negative.
Single-fiber electromyography (SFEMG) is the most sensitive diagnostic test for myasthenia gravis. It can detect abnormal neuromuscular transmission even when antibody tests and standard EMG are normal.
Key Takeaways
- Most sensitive test for myasthenia gravis (~95-99%)
- Detects abnormal neuromuscular transmission
- Useful when other tests negative
- Measures "jitter" between nerve signals
- Performed by specialized neurologists
How It Works
Normal Neuromuscular Transmission
When a nerve signals a muscle to contract:
- Nerve releases acetylcholine
- Acetylcholine binds to muscle receptors
- Muscle fires with consistent timing
The time between nerve signal and muscle response should be very consistent.
Abnormal Transmission in Myasthenia
- Antibodies damage acetylcholine receptors
- Transmission becomes unreliable
- Timing varies (increased "jitter")
- Sometimes transmission fails completely ("blocking")
What SFEMG Measures
Jitter: Variation in timing between nerve signal and muscle response
- Normal: Very consistent timing
- Abnormal: Variable timing (increased jitter)
Blocking: Complete failure of transmission
- Indicates more severe involvement
When SFEMG Is Ordered
- Suspected myasthenia gravis with negative antibodies
- Ocular myasthenia (often seronegative)
- Normal repetitive nerve stimulation but clinical suspicion high
- Confirming diagnosis when other tests inconclusive
The Procedure
Preparation
- May need to stop pyridostigmine temporarily (ask your doctor)
- No special preparation otherwise
- Takes 30-60 minutes
During the Test
- Small needle electrode inserted into muscle
- Usually tested in forehead (frontalis) or forearm (extensor digitorum)
- Multiple muscle fiber pairs examined
- You'll be asked to gently contract the muscle
- May feel mild discomfort
After the Test
- Minimal discomfort
- Can resume normal activities
- No special care needed
Interpreting Results
Abnormal SFEMG
- Increased jitter values
- May have blocking
- Supports diagnosis of myasthenia gravis
- But not specific—other conditions can cause abnormal jitter
Normal SFEMG
- Makes myasthenia gravis less likely
- But doesn't completely rule it out
- May be normal in very mild or localized disease
Sensitivity and Specificity
| Test | Sensitivity for Generalized MG |
|---|---|
| AChR antibodies | ~85% |
| Repetitive nerve stimulation | ~75% |
| Single-fiber EMG | ~95-99% |
For ocular myasthenia:
- SFEMG sensitivity ~85-90%
- Much higher than antibody tests (~50%)
Limitations
Not Specific for Myasthenia
Other conditions can cause increased jitter:
- Other neuromuscular diseases
- Motor neuron disease
- Some neuropathies
- Recent botulinum toxin injection
Operator Dependent
- Requires specialized training
- Results depend on examiner skill
- Not available at all centers
Muscle Selection
- Results may vary by muscle tested
- Clinically affected muscles may be harder to test
- Frontalis often used for suspected ocular MG
Comparison with Other Tests
vs. Repetitive Nerve Stimulation (RNS)
| Feature | SFEMG | RNS |
|---|---|---|
| Sensitivity | Higher | Lower |
| Specificity | Lower | Higher |
| Availability | Specialized centers | Widely available |
| Duration | Longer | Shorter |
vs. Antibody Testing
- SFEMG more sensitive than AChR antibodies
- Antibodies more specific when positive
- Tests are complementary
What to Expect from Results
If Abnormal
- Supports myasthenia diagnosis
- Further workup may include CT chest (thymoma)
- Treatment discussion
If Normal
- Makes myasthenia less likely
- Consider other diagnoses
- May repeat if clinical suspicion remains
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
Medically Reviewed Content
This article meets our editorial standards
- Written by:
- Hashemi Eye Care Medical Team
- Medically reviewed by:
- Board-Certified Neuro-Ophthalmologist (MD, Neuro-Ophthalmology)
- Last reviewed:
- January 30, 2025
